Variant-related differences in laboratory biomarkers among patients affected with alpha, delta and omicron: a retrospective whole viral genome sequencing and …

G Meletis, A Tychala, G Ntritsos, E Verrou, F Savvidou… - Biomedicines, 2023 - mdpi.com
During the COVID-19 pandemic, different SARS-CoV-2 variants of concern (VOC) with
specific characteristics have emerged and spread worldwide. At the same time, clinicians …

Modeling mortality risk in patients with severe COVID-19 from Mexico

A Cortes-Telles, E Figueroa-Hurtado… - Frontiers in …, 2023 - frontiersin.org
Background Severe acute respiratory syndrome caused by a coronavirus (SARS-CoV-2) is
responsible for the COVID-19 disease pandemic that began in Wuhan, China, in December …

Cell‐Based Biomaterials for Coronavirus Disease 2019 Prevention and Therapy

C Li, C Wang, HY Xie, L Huang - Advanced Healthcare …, 2023 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) continues to threaten human health,
economic development, and national security. Although many vaccines and drugs have …

Generation and assessment of useful and privacy preserving synthetic datasets

F Gewirtz-O'Reilly - 2024 - theses.gla.ac.uk
Synthetic datasets are gaining traction as a potential solution for allowing access to sensitive
data while protecting the privacy of individuals. However, the assessment of both the utility …